That extended residence time creates a perfect environment for bacterial fermentation
Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 medications, have recently gained popularity in the modern medical world for the treatment of diabetes and obesity
Kenneth Bilchick, MD, a UVA Health heart rhythm specialist who co-led the study along with Tiago Palmisano, MD, and David Guarraia, MD, explained, The survival curves in all three groups indicated that there was a reduction in the risk of incident atrial fibrillation regardless of whether you gained weight, lost a little weight, or lost a lot of weight. Among the medicines studied, semaglutide showed the strongest association with reduced Afib risk
Each year there is a different topic, and we are presented with the most up-to-date research in that area
Kelly Clarkson revealed that her recent weight loss was a result of her being diagnosed as pre-diabetic a couple years ago